|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 732.2 USD | -1.81% |
|
-2.47% | +25.61% |
| Apr. 23 | Global markets live: Bayer, PepsiCo, Halliburton, Spotify, Apple... |  |
| Apr. 23 | Alzheimer's drug adoption in US slowed by doctors' skepticism | RE |
On November 18, 2021, Fountain Therapeutics, Inc closed the transaction. The transaction included participation from new investors Eli Lilly and Company, Alexandria Venture Investments, LLC, R42 Group, returning investors Khosla Ventures, LLC and Nan Fung Life Sciences. This round of funding brings its total Series A funding to $26,000,000.
The company has raised funding pursuant to Regulation D from eight investors.
| 1st Jan change | Capi. | |
|---|---|---|
| +25.61% | 660B | |
| +25.87% | 562B | |
| -5.24% | 358B | |
| +16.49% | 322B | |
| +8.28% | 297B | |
| +7.09% | 219B | |
| -9.12% | 196B | |
| +5.01% | 199B | |
| -8.75% | 149B | |
| -5.21% | 146B |
ELI LILLY AND COMPANY 
